跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 67 条关于
“ENGOT”
全部
67
临床试验
35
药物
0
机构
0
资讯
32
去年
Lenvatinib Plus Pembrolizumab Demonstrates Significant Antitumor Activity in Advanced Endometrial Cancer
2年前
Pembrolizumab Fails to Improve DFS in High-Risk Endometrial Cancer, Shows Promise in dMMR Subgroup
3年前
FDA Grants Priority Review to GSK's Jemperli for Advanced Endometrial Cancer
去年
ESMO Congress Highlights Immunotherapy Advancements in Multiple Cancers
去年
Mixed Results for Adjuvant Therapies in Solid Tumors: Key Takeaways From ESMO 2024
去年
Atezolizumab Fails to Improve Progression-Free Survival in Recurrent Ovarian Cancer
11个月前
Atezolizumab Shows Mixed Results in Advanced Endometrial Cancer Trial, Benefits dMMR Patients
去年
GSK's Jemperli and Zejula Combo Shows Promise in Advanced Ovarian Cancer
9个月前
DESTINY-Ovarian01 Phase 3 Trial Launches to Test ENHERTU as First-Line Maintenance Therapy for HER2-Expressing Ovarian Cancer
去年
Molecular Testing Advances Personalized Treatment Strategies in Ovarian Cancer
第 1 页,共 4 页
上一页
下一页